$PBIO Pressure BioSciences Announces Commercial Av
Post# of 1354
(Total Views: 201)
Posted On: 05/22/2023 12:24:01 PM
$PBIO Pressure BioSciences Announces Commercial Availability of Best-in-Class Nano-CBD Topical Spray, Featuring Lightning-Fast Action from PBI's UltraShear Processing
https://www.accesswire.com/756357/Pressure-Bi...Processing
Leading CBD Retailer (CBD Supply MD) Today Introduces the "NanoBloom CBD" Topical Spray Through Their Mid-Atlantic Store Chain and Their Highly Effective, Nationwide, On-Line Retail Store
SOUTH EASTON, MA / ACCESSWIRE / May 22, 2023 / Pressure BioSciences, Inc. (OTCQB
BIO) ("PBIO" or the "Company"
, a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables, and specialty testing services to the worldwide biotherapeutics nutraceuticals, cosmeceuticals, food and beverage, and other industries, and CBD Supply MD, one of the largest and best-known retail suppliers of CBD products in the multi-state mid-Atlantic region, today announced the commercial introduction and availability of their "NanoBloom CBD" Topical Spray, a leap forward in best-in-class, super-fast acting, highly bioavailable hemp-derived, all natural, CBD Topical Spray, also delivering rock solid multi-year stability.
NanoBloom CBD was formulated for ideal speedy effectiveness and optimal potency, finally addressing and resolving consumers' primary unmet objectives for CBD topical applications. In addition to its speed of action and potency breakthroughs, NanoBloom CBD is believed to be the only pharma-grade, preservative-free, all natural, Nano-CBD product available in the U.S. today, if not the world. The distribution agreement between the companies is for a minimum of two years and is expected to generate over $1.5 million in revenue for PBIO in the first year alone.
Mr. Keith E. Manley, Co-founder of CBD Supply MD, commented: "We are utterly thrilled and honored to introduce the first Ultra Shear Technology™ (UltraShear™ or UST™) processed product to the open market nationwide. Academic bioavailability data and consumer focus group feedback has convincingly demonstrated that PBIO's revolutionary UltraShear platform generates nanoemulsions of unmatched fast and complete bioavailability and long-term shelf stability, presenting a value proposition that is unparalleled in the industry. We are certain that the NanoBloom CBD product is destined to become a true game-changer. Happily, this is the first of many UltraShear nanoemulsified products we plan to bring to market with our new partner PBIO. As excited as this is for me personally and our CBD Supply MD team, I know our enthusiasm will pale in comparison to the benefits our customers are about to receive and understand."
Mr. John B. Hollister, Director of Sales and Marketing at PBIO, said: "CBD Supply MD is a highly respected market leader, with one of the largest established customer bases in the mid-Atlantic region, and with nationwide reach through their highly-effective website. We are excited that their customers will now have the opportunity to benefit from a best-in-class, UltraShear Nano-CBD product - in their NanoBloom CBD Topical Spray. We look forward to developing multiple additional product formulations with CBD Supply MD beyond this initial but substantial $1.5M CBD product agreement."
Mr. Richard T. Schumacher, PBIO's President and CEO summed up: "Our diverse work on UltraShear nanoemulsion processing across nutraceutical, cosmeceutical, pharmaceutical, agrochemical, and food/beverage markets has generated an exciting array of developing commercial opportunities for PBI. We are excited to announce initial commercialization with CBD Supply MD - and grateful to have the opportunity to work with such a highly respected retail sales leader in CBD products and the broader cannabis marketplace. We are negotiating with multiple companies interested in rights to our UltraShear processed nanoemulsion products and expect to announce a number of additional supply agreements in the coming weeks. All told, we expect that revenue from UltraShear processing in 2023 will quickly diversify across multiple major opportunities in nutraceuticals, cosmeceuticals and beyond, far exceeding revenue from all other PBIO products."
https://www.accesswire.com/756357/Pressure-Bi...Processing
Leading CBD Retailer (CBD Supply MD) Today Introduces the "NanoBloom CBD" Topical Spray Through Their Mid-Atlantic Store Chain and Their Highly Effective, Nationwide, On-Line Retail Store
SOUTH EASTON, MA / ACCESSWIRE / May 22, 2023 / Pressure BioSciences, Inc. (OTCQB
BIO) ("PBIO" or the "Company" , a global leader in the development and sale of broadly enabling, high-pressure-based equipment, consumables, and specialty testing services to the worldwide biotherapeutics nutraceuticals, cosmeceuticals, food and beverage, and other industries, and CBD Supply MD, one of the largest and best-known retail suppliers of CBD products in the multi-state mid-Atlantic region, today announced the commercial introduction and availability of their "NanoBloom CBD" Topical Spray, a leap forward in best-in-class, super-fast acting, highly bioavailable hemp-derived, all natural, CBD Topical Spray, also delivering rock solid multi-year stability. NanoBloom CBD was formulated for ideal speedy effectiveness and optimal potency, finally addressing and resolving consumers' primary unmet objectives for CBD topical applications. In addition to its speed of action and potency breakthroughs, NanoBloom CBD is believed to be the only pharma-grade, preservative-free, all natural, Nano-CBD product available in the U.S. today, if not the world. The distribution agreement between the companies is for a minimum of two years and is expected to generate over $1.5 million in revenue for PBIO in the first year alone.
Mr. Keith E. Manley, Co-founder of CBD Supply MD, commented: "We are utterly thrilled and honored to introduce the first Ultra Shear Technology™ (UltraShear™ or UST™) processed product to the open market nationwide. Academic bioavailability data and consumer focus group feedback has convincingly demonstrated that PBIO's revolutionary UltraShear platform generates nanoemulsions of unmatched fast and complete bioavailability and long-term shelf stability, presenting a value proposition that is unparalleled in the industry. We are certain that the NanoBloom CBD product is destined to become a true game-changer. Happily, this is the first of many UltraShear nanoemulsified products we plan to bring to market with our new partner PBIO. As excited as this is for me personally and our CBD Supply MD team, I know our enthusiasm will pale in comparison to the benefits our customers are about to receive and understand."
Mr. John B. Hollister, Director of Sales and Marketing at PBIO, said: "CBD Supply MD is a highly respected market leader, with one of the largest established customer bases in the mid-Atlantic region, and with nationwide reach through their highly-effective website. We are excited that their customers will now have the opportunity to benefit from a best-in-class, UltraShear Nano-CBD product - in their NanoBloom CBD Topical Spray. We look forward to developing multiple additional product formulations with CBD Supply MD beyond this initial but substantial $1.5M CBD product agreement."
Mr. Richard T. Schumacher, PBIO's President and CEO summed up: "Our diverse work on UltraShear nanoemulsion processing across nutraceutical, cosmeceutical, pharmaceutical, agrochemical, and food/beverage markets has generated an exciting array of developing commercial opportunities for PBI. We are excited to announce initial commercialization with CBD Supply MD - and grateful to have the opportunity to work with such a highly respected retail sales leader in CBD products and the broader cannabis marketplace. We are negotiating with multiple companies interested in rights to our UltraShear processed nanoemulsion products and expect to announce a number of additional supply agreements in the coming weeks. All told, we expect that revenue from UltraShear processing in 2023 will quickly diversify across multiple major opportunities in nutraceuticals, cosmeceuticals and beyond, far exceeding revenue from all other PBIO products."
(0)
(0)